Morinda, Inc.

Tahitian Noni International, Inc.

Stephen P Story

Afa Kehaati Palu

Chen Su

Bing-Nan Zhou

Claude Jarakae Jensen

Brett Justin West

John J Wadsworth

Robert Ogden

C Jarakae Jensen

Claude Jarake Jensen

Scott Gerson

Claude Jarkae Jensen

Shixin Deng

Richard G Godbee

Johannes Joseph Westendorf

Shixin Dong

John W Wadsworth

Mian Ying Wang

Summer Jensen

The present invention relates to methods and formulations directed to the management of Cathepsin G, Cathepsin S, Cathepsin B, Cathepsin L, Butyryl Cholinesterase, Peptidase HIV-1, and NF-kB enzymes comprising the administration of processedbased formulations.

[object Object]

This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plantto individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf More particularly this invention relates to administering one or more of the following: Pyro-phorbide a, Pheophorbide a, Purpin 7, and/or Pheophorbide all which may be derived from Noni leaf extract, Noni leaf juice, and/or Roast leaf Moreover, the foregoing formulations result in alleviating pain and inflammation.

Implementation is directed to selectively inhibiting estrogen production and providing estrogenic effects in a human body. A dietary supplement includes a processedproduct that is used to inhibit aromatase or aromatase enzymes that function to convert androgens to estrogens, inhibit receptors from binding with estrogen, and reduce and/or regulate estrogen production, as well as reduce the amount of estrogen produced within the body and regulating such production. The dietary supplement further provides estrogenic effects. The present invention methods and compositions effectively function to treat estrogen-dependent cancers, and particularly inhibit, destroy, and reverse the effects of of estrogen-dependent cancerous tumors through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processedproducts for a safe, pre-determined duration.

Selectively inhibiting estrogen production and providing estrogenic effects in the human body

This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plantto individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf. More particularly this invention relates to administering one or more of the following: Pyro-phorbide a, Pheophorbide a, Purpin 7, and/or Pheophorbide all which may be derived from Noni leaf extract, Noni leaf juice, and/or Roast leaf. Moreover, the foregoing formulations result in alleviating pain and inflammation.

Methods and compositions relating to leaf extracts obtained fromleaves. Methods and compositions relating to a leaf serum created from combining leaf extract and fruit juice from theL. plant. Methods and compositions relating to leaf extract compositions comprising one or more of the leaf extracts and leaf serums.

The present invention advances prior art animal food products by providing an animal food product formulated with., or Mangosteen fruit, from the Mangosteen plant. The addition of Mangosteen to the animal food product of the present invention serves to provide significant health advantages not found in prior art animal food products.

The present invention features methods and formulations or compositions for the treatment of colon cancer, and particularly for the inhibition, prevention and/or reduction of cancerous cell growth, as well as the destruction of early stage cancerous cells within the colon region of a mammal, wherein the formulations and compositions comprise an identified amount or concentration of a processedproduct or an active ingredient there from, as obtained from the Indian Mulberry plant.

Preventative and treatment effects of morinda citrifolia as a colon cancer cell growth inhibitor

The present invention relates to antifungal and antibacterial activity of processedproducts, as well as from various fractions of extracts from these processed products and the. plant, and related methods to determine mean inhibitory concentrations. In particular, the present invention relates to ethanol, methanol and ethyl acetate extracts from. and their inhibitory activities on common fungi and bacteria and the identification of mean inhibitory concentrations.

Formulation for inhibiting fungal and microbial growth comprising morinda citrifolia puree juice

The use of an improved method for freeze concentration is disclosed. The method provides for first freezing components of a pulpy slurry of. More dilute components are extracted after the initial freezing. A secondary freezing process at a lower temperature allows more concentrated portions of aslurry to be removed. Flavor and therapeutic oils remain in the resulting concentrate for improved flavor and health benefits.

Freeze concentration process

The present invention advances prior art animal food products by providing an animal food product formulated with or Noni, from the Indian Mulberry plant. The addition of Noni to the animal food product of the present invention serves to provide significant health advantages not found in prior art animal food products.

Morinda citrifolia (Noni) enhanced animal food product

A dietary fiber product obtained from the Indian mulberry ( ) plant and the process of extracting and purifying the fiber is disclosed. According to one embodiment, the Indian mulberry pulp is washed and separated from the juice by filtration. The wet pulp is pasteurized. The wet pulp can be further processed by drying. A high fiber products can be prepared by mixing the pulp with ingredients, such as supplemental dietary fiber, water, sweeteners, flavoring agents, coloring agents, and nutritional ingredients.

Morinda citrifolia dietary fiber

An essential oil product obtained from the Indian mulberry ( ) plant and the process of extracting and purifying the oil is disclosed. According to one embodiment, the seeds from the Indian mulberry fruit are dried, preferably to a moisture content less than 10%. The seeds are ground or shredded to facilitate the removal of natural occurring oil. The shredded or ground flakes are pressed to expel oil. The remaining seed cake is then mixed with a food grade, non-polar extraction solvent such as hexane. The mixture is heated for a sufficient length of time to complete the extraction process. The extraction solvent is then evaporated from the mixture leaving the oil. The oil is further refined, bleached, dried, and deodorized to remove free fatty acids and other unwanted components. An antioxidant can optionally be added to stabilize the oil for further processing or packaging.

Morinda citrifolia oil

A dietary fiber product obtained from the Indian mulberry (,) plant and the process of extracting and purifying the fiber is disclosed. According to one embodiment, the Indian mulberry pulp is washed and separated from the juice by filtration. The wet pulp is pasteurized. The wet pulp can be further processed by drying. A high fiber products can be prepared by mixing the pulp with ingredients, such as supplemental dietary fiber, water, sweeteners, flavoring agents, coloring agents, and nutritional ingredients.

Morinda citrifolia dietary fiber and method

An essential oil product obtained from the Indian mulberry (,) plant and the process of extracting and purifying the oil is disclosed. According to one embodiment, the seeds from the Indian mulberry fruit are dried, preferably to a moisture content less than 10%. The seeds are ground or shredded to facilitate the removal of natural occurring oil. The shredded or ground flakes are pressed to expel,oil. The remaining seed cake is then mixed with a food grade, non-polar extraction solvent such as hexane. The mixture is heated for a sufficient length of time to complete the extraction process. The extraction solvent is then evaporated from the mixture leaving the,oil. The oil is further refined, bleached, dried, and deodorized to remove free fatty acids and other unwanted components. An antioxidant can optionally be added to stabilize the oil for further processing or packaging.

Growing community of inventors

Alpine, UT, United States of America

Stephen P Story